Evidence map›Paper›PMID 38081955›Full record

ArticleJournal of behavioral medicine2024

High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa.

Emily Krogstad Mudzingwa, Lindsey de Vos, Millicent Atujuna, Lauren Fynn, Matinatsa Mugore, Selly Mabandla, Sybil Hosek, Connie Celum, Linda-Gail Bekker, Joseph Daniels and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of behavioral medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03977181 (Leveraging Community-based Platforms to Improve Access and Adherence to PrEP for Young Women in South Africa), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03977181 nacompletednot on this map

Leveraging Community-based Platforms to Improve Access and Adherence to PrEP for Young Women in South Africa

TypeinterventionalSponsorFoundation for Professional Development (Pty) LtdRan2018 to 2021Enrolled480ConditionsPrEP, HIV Prevention, Adolescence, Cost-effectivenessArmsGroup-based Community Health Club, Individual-based Adherence Support
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emily Krogstad MudzingwaThe Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa.
Lindsey de VosResearch Unit, Foundation for Professional Development, Buffalo City Metro, Eastern Cape Province, South Africa.
Millicent AtujunaThe Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa.
Lauren FynnThe Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa.
Matinatsa MugoreMailman School of Public Health, Columbia University, New York, NY, USA.
Selly MabandlaHIV/AIDS, STIs and TB Directorate, Buffalo City Health District, Eastern Cape Provincial Department of Health, Bisho, South Africa.
Sybil HosekDepartment of Psychiatry, Stroger Hospital of Cook County, Chicago, IL, USA.
Connie CelumDepartment of Global Health, University of Washington, Seattle, WA, USA.
Linda-Gail BekkerThe Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa.
Joseph DanielsEdson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA.
Andrew Medina-MarinoThe Desmond Tutu HIV Centre, University of Cape Town, Desmond Tutu Health Foundation, 3 Woodlands Road, Woodstock, Cape Town, 7915, South Africa. andrewmedinamarino@gmail.com.ORCID 0000-0002-0095-4141

Funding

The Community PrEP StudyR01MH114648 · NIMH · FOUNDATION FOR PROFESSIONAL DEVELOPMENT · PI BEKKER, LINDA-GAIL GAIL, MEDINA-MARINO, ANDREW · 2017 to 2021
$2.4M
NIMH NIH HHS R01 MH114648NIMH NIH HHS R01MH114648
6 · The paper itself

Abstract

In Southern and Eastern Africa, initiation of daily oral pre-exposure prophylaxis (PrEP) for HIV prevention has been high among adolescent girls and young women (AGYW) offered PrEP. However, persistence and prevention-effective use of PrEP among this critical group continues to be a challenge. We conducted a qualitative sub-study of AGYW from the Community PrEP Study in Eastern Cape Province, South Africa who had high rates of pick up for monthly PrEP refills over two years, but differing levels of PrEP adherence based on tenofovir-diphosphate (TFV-DP) measurements in dried blood spots (DBS). Contrasting 22 AGYW with low versus high levels of TFV-DP in DBS, we qualitatively explored factors which influenced PrEP persistence vs. non-persistence, unique patterns of PrEP use (e.g., discarding or stockpiling), and participant recommendations for improving AGYW prevention-effective use of PrEP in the future. Results showed that PrEP misconceptions and mistrust among participants' social networks negatively influenced adherence. In comparison, supportive families and/or partners and personal trust that PrEP works positively influenced adherence. Those with low adherence described being motivated to come to the site for other study benefits (e.g., reimbursement money, snacks, sanitary pads) and discarding PrEP to avoid stigma associated with being seen with pills. Future PrEP implementation strategies should focus on involving families and partners in PrEP support for AGYW and minimizing PrEP stigma at a community level.Trial registration NCT03977181. Retrospectively registered on June 6, 2019.

Indexed as

Anti-HIV AgentsHIV InfectionsOrganophosphatesAdenineAdolescentCognitionFemaleHumansQualitative ResearchSouth AfricaAdenineAnti-HIV AgentsOrganophosphatestenofovir diphosphateAdherenceAdolescent girls and young womenHIV preventionPre-exposure prophylaxisSouth Africa

Identifiers

PMID38081955
PMCPMC10944421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.